Loading...
Raffles Medical Group Ltd
BSL.SI•SES
Healthcare
Medical - Care Facilities
S$1.02
S$0.00(0.00%)
Raffles Medical Group Ltd (BSL.SI) Financial Performance & Statements
Review Raffles Medical Group Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.15%
↑ 6.15%
Operating Income Growth
-28.73%
↓ 28.73%
Net Income Growth
-30.96%
↓ 30.96%
Operating Cash Flow Growth
-54.44%
↓ 54.44%
Operating Margin
10.68%
↑ 10.68%
Gross Margin
49.40%
↑ 49.40%
Net Profit Margin
8.57%
↑ 8.57%
ROE
4.46%
↑ 4.46%
ROIC
4.96%
↑ 4.96%
Raffles Medical Group Ltd (BSL.SI) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Raffles Medical Group Ltd stock.
| Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $182.84M | $182.84M | $168.59M | $168.59M |
| Cost of Revenue | $100.71M | $100.71M | $68.96M | $68.96M |
| Gross Profit | $82.14M | $82.14M | $99.63M | $99.63M |
| Gross Profit Ratio | $0.45 | $0.45 | $0.59 | $0.59 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $41.77M | $41.77M | $70.09M | $70.09M |
| Operating Expenses | $61.50M | $61.50M | $80.09M | $80.09M |
| Total Costs & Expenses | $162.21M | $162.21M | $149.05M | $149.05M |
| Interest Income | $5.30M | $1.07M | $5.23M | $962000.00 |
| Interest Expense | $3.16M | $0.00 | $3.36M | $0.00 |
| Depreciation & Amortization | $9.36M | $9.36M | $3.40M | $3.40M |
| EBITDA | $30.003M | $30.003M | $19.16M | $19.16M |
| EBITDA Ratio | $0.16 | $0.16 | $0.11 | $0.11 |
| Operating Income | $20.64M | $20.64M | $15.76M | $15.76M |
| Operating Income Ratio | $0.11 | $0.11 | $0.09 | $0.09 |
| Other Income/Expenses (Net) | $1.07M | $1.07M | $4.75M | $4.75M |
| Income Before Tax | $21.71M | $21.71M | $20.51M | $20.51M |
| Income Before Tax Ratio | $0.12 | $0.12 | $0.12 | $0.12 |
| Income Tax Expense | $6.24M | $6.24M | $5.17M | $5.17M |
| Net Income | $15.32M | $15.32M | $15.15M | $15.15M |
| Net Income Ratio | $0.08 | $0.08 | $0.09 | $0.09 |
| EPS | $0.008 | $0.008 | $0.008 | $0.008 |
| Diluted EPS | $0.008 | $0.008 | $0.008 | $0.008 |
| Weighted Avg Shares Outstanding | $1.89B | $1.89B | $1.87B | $1.87B |
| Weighted Avg Shares Outstanding (Diluted) | $1.89B | $1.89B | $1.87B | $1.87B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan